- Home
- IMMP vs ACCD Comparison
IMMP vs ACCD Comparison
Compare IMMP & ACCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- ACCD
- Stock Information
- Founded
- IMMP 1987
- ACCD 2007
- Country
- IMMP Australia
- ACCD United States
- Employees
- IMMP N/A
- ACCD N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- ACCD Business Services
- Sector
- IMMP Health Care
- ACCD Consumer Discretionary
- Exchange
- IMMP Nasdaq
- ACCD Nasdaq
- Market Cap
- IMMP 264.7M
- ACCD 286.7M
- IPO Year
- IMMP N/A
- ACCD 2020
- Fundamental
- Price
- IMMP $2.05
- ACCD $3.47
- Analyst Decision
- IMMP Buy
- ACCD Buy
- Analyst Count
- IMMP 2
- ACCD 12
- Target Price
- IMMP $8.50
- ACCD $9.04
- AVG Volume (30 Days)
- IMMP 106.2K
- ACCD 1.3M
- Earning Date
- IMMP 11-26-2024
- ACCD 01-06-2025
- Dividend Yield
- IMMP N/A
- ACCD N/A
- EPS Growth
- IMMP N/A
- ACCD N/A
- EPS
- IMMP N/A
- ACCD N/A
- Revenue
- IMMP $2,563,302.00
- ACCD $441,028,000.00
- Revenue This Year
- IMMP N/A
- ACCD $15.56
- Revenue Next Year
- IMMP $10.84
- ACCD $11.76
- P/E Ratio
- IMMP N/A
- ACCD N/A
- Revenue Growth
- IMMP 9.59
- ACCD 16.04
- 52 Week Low
- IMMP $1.58
- ACCD $3.08
- 52 Week High
- IMMP $3.34
- ACCD $15.36
- Technical
- Relative Strength Index (RSI)
- IMMP 55.82
- ACCD 47.12
- Support Level
- IMMP $1.85
- ACCD $3.08
- Resistance Level
- IMMP $2.06
- ACCD $3.80
- Average True Range (ATR)
- IMMP 0.10
- ACCD 0.17
- MACD
- IMMP 0.03
- ACCD 0.05
- Stochastic Oscillator
- IMMP 70.89
- ACCD 54.17
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About ACCD Accolade Inc.
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.